LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
Halozyme Therapeutics
HALO
New Fortress Energy
NFE
YETI Holdings
YETI
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 52.07%378.2M | 49.21%378.4M | 227.38%137.5M | 689.33%900.5M | 97.12%356.2M | 5,552.27%248.7M | 223.29%253.6M | 131.77%42M | -172.45%-152.8M | 395.07%180.7M |
Net income from continuing operations | 87.67%176.6M | 114.06%178.1M | -111.73%-5.9M | 500.78%460.2M | 774.44%232.6M | 343.87%94.1M | 309.85%83.2M | 491.76%50.3M | -35.95%76.6M | 20.91%26.6M |
Operating gains losses | 9.09%67.2M | -44.78%25.4M | 4,304.76%176.6M | 266.91%157.9M | 85.37%54.5M | 528.57%61.6M | 218.25%46M | 95.57%-4.2M | -252.83%-94.6M | 219.57%29.4M |
Depreciation and amortization | 1.03%68.9M | 1.63%68.4M | 3.15%68.7M | -10.38%271M | -2.27%68.9M | -9.91%68.2M | -12.60%67.3M | -15.91%66.6M | 33.22%302.4M | 0.86%70.5M |
Deferred tax | -2,086.96%-50.3M | 366.67%4.8M | -323.53%-7.6M | -1,430.23%-131.6M | -1,076.87%-130.9M | 82.03%-2.3M | 60.87%-1.8M | 173.91%3.4M | 92.91%-8.6M | 113.10%13.4M |
Other non cash items | 1,103.45%34.9M | -514.29%-2.9M | -152.05%-3.8M | 1,351.22%51.3M | 8.02%40.4M | 111.33%2.9M | 114.00%700K | 166.97%7.3M | -116.67%-4.1M | 679.17%37.4M |
Change In working capital | 311.30%72.8M | 86.96%96.1M | -14.73%-99.7M | 114.85%66.7M | 7,141.67%84.5M | 125.21%17.7M | 119.64%51.4M | 25.15%-86.9M | -238.25%-449.2M | -104.41%-1.2M |
-Change in receivables | -157.75%-75.3M | 32.14%-125M | 110.99%9.9M | 27.49%-272.5M | -8.25%-128.6M | 249.54%130.4M | -11.64%-184.2M | -1,777.08%-90.1M | -220.10%-375.8M | -139.52%-118.8M |
-Change in inventory | -2,714.00%-140.7M | -591.76%-117.6M | -33.96%-106.5M | 74.46%-54M | 621.98%47.5M | 67.11%-5M | 36.33%-17M | 50.44%-79.5M | -68.18%-211.4M | -141.36%-9.1M |
-Change in payables and accrued expense | 1,452.52%188M | 124.79%183.2M | -18.41%-71.4M | 19.96%119M | -6.53%111.7M | -146.18%-13.9M | 260.12%81.5M | -12,160.00%-60.3M | 87.52%99.2M | 59,850.00%119.5M |
-Change in other current assets | 86.17%-16.2M | -99.48%800K | -2,541.67%-31.7M | --0 | -45.12%-35.7M | -2,118.97%-117.1M | 3,322.22%154M | 91.72%-1.2M | -1,471.43%-28.8M | -8,100.00%-24.6M |
-Change in other working capital | 402.15%117M | 804.68%154.7M | -30.65%100M | 305.62%274.2M | 181.76%89.6M | 729.73%23.3M | 172.46%17.1M | 128.53%144.2M | 22.24%67.6M | --31.8M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 52.07%378.2M | 49.21%378.4M | 227.38%137.5M | 689.33%900.5M | 97.12%356.2M | 5,552.27%248.7M | 223.29%253.6M | 131.77%42M | -172.45%-152.8M | 395.07%180.7M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -43.07%-39.2M | -71.10%-45M | -109.77%-36.5M | -24.09%-139.1M | -81.82%-68M | -10.48%-27.4M | 17.03%-26.3M | 4.40%-17.4M | 90.79%-112.1M | 96.80%-37.4M |
Capital expenditure reported | -43.07%-39.2M | -71.10%-45M | -22.48%-36.5M | -21.26%-134.6M | -23.73%-51.1M | -10.48%-27.4M | 1.50%-26.3M | -63.74%-29.8M | -31.21%-111M | -29.87%-41.3M |
Net PPE purchase and sale | --0 | --0 | --0 | 217.95%12.4M | --0 | --0 | --0 | --12.4M | -60.20%3.9M | 5.41%3.9M |
Net business purchase and sale | ---- | ---- | ---- | -238.00%-16.9M | ---- | ---- | ---- | ---- | 99.56%-5M | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -43.07%-39.2M | -71.10%-45M | -109.77%-36.5M | -24.09%-139.1M | -81.82%-68M | -10.48%-27.4M | 17.03%-26.3M | 4.40%-17.4M | 90.79%-112.1M | 96.80%-37.4M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -333.33%-16.8M | 90.89%-20.5M | -3,107.98%-603.1M | -347.01%-247.5M | 92.53%-10.8M | -92.11%7.2M | -245.23%-225.1M | -1,153.33%-18.8M | -89.05%100.2M | -117.44%-144.5M |
Net issuance payments of debt | 1.85%-5.3M | 97.70%-5.3M | 74.64%-5.3M | -219.90%-262.1M | 92.14%-5.3M | -105.19%-5.4M | -234.25%-230.5M | -302.91%-20.9M | -73.61%218.6M | -107.98%-67.4M |
Net common stock issuance | --0 | --0 | ---599.9M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Cash dividends paid | ---9.4M | ---9.4M | ---9.3M | -150.00%-9.5M | ---9.5M | --0 | --0 | --0 | 0.00%-3.8M | ---- |
Proceeds from stock option exercised by employees | -89.15%1.4M | 17.95%9.2M | 554.55%14.4M | 783.87%27.4M | 150.00%4.5M | 6,350.00%12.9M | 7,700.00%7.8M | 120.00%2.2M | -97.22%3.1M | 20.00%1.8M |
Net other financing activities | -1,066.67%-3.5M | -525.00%-15M | -2,900.00%-3M | 97.20%-3.3M | 99.33%-500K | 97.69%-300K | 85.71%-2.4M | 99.22%-100K | -457.82%-117.7M | -440.29%-75.1M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -333.33%-16.8M | 90.89%-20.5M | -3,107.98%-603.1M | -347.01%-247.5M | 92.53%-10.8M | -92.11%7.2M | -245.23%-225.1M | -1,153.33%-18.8M | -89.05%100.2M | -117.44%-144.5M |
Net cash flow | ||||||||||
Beginning cash position | 109.74%587.7M | -0.11%280.5M | 188.65%788.6M | -38.90%273.2M | 87.94%505M | 36.48%280.2M | -5.30%280.8M | -38.90%273.2M | -17.60%447.1M | -64.25%268.7M |
Current changes in cash | 41.01%322.2M | 14,122.73%312.9M | -8,756.90%-502.1M | 412.02%513.9M | 23,216.67%277.4M | 222.74%228.5M | 102.67%2.2M | 103.82%5.8M | -80.99%-164.7M | 99.61%-1.2M |
Effect of exchange rate changes | 302.70%7.5M | -103.57%-5.7M | -433.33%-6M | 116.30%1.5M | 8.77%6.2M | 50.00%-3.7M | 68.18%-2.8M | 38.46%1.8M | -104.44%-9.2M | 714.29%5.7M |
End cash Position | 81.66%917.4M | 109.74%587.7M | -0.11%280.5M | 188.65%788.6M | 188.65%788.6M | 87.94%505M | 36.48%280.2M | -5.30%280.8M | -38.90%273.2M | -38.90%273.2M |
Free cash flow | 53.19%339M | 46.68%333.4M | 727.87%101M | 390.33%765.9M | 118.87%305.1M | 1,184.80%221.3M | 197.81%227.3M | 108.11%12.2M | -308.87%-263.8M | 2,865.96%139.4M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |